INTERNATIONAL PATENT: FORTVITA BIOLOGICS INC., 福佑泰生物制药公司 FILES APPLICATION FOR "BISPECIFIC ANTIBODY-DRUG CONJUGATE TARGETING TROP2XPD-L1 AND PREPARATION METHOD THEREFOR AND USE THEREOF"

Posted On: 2025-11-10

GENEVA, Nov. 10 -- FORTVITA BIOLOGICS INC. (Vistra (Cayman) Limited, P.O. Box 31119 Grand Pavilion, Hibiscus Way, 802 West Bay Road, Grand Cayman KY1-1205), 福佑泰生物制药公司 (开曼群岛大开曼岛KY1-1205，西湾路802号，扶桑花路，格兰德大厦，邮政信箱31119) filed a patent application (PCT/CN2025/091460) for "BISPECIFIC ANTIBODY-DRUG CONJUGATE TARGETING TROP2XPD-L1, AND PREPARATION METHOD THEREFOR AND USE THEREOF" on Apr 27, 2025. With publication no. WO/2025/228298, the details related to the patent application was publis...

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

INTERNATIONAL PATENT: FORTVITA BIOLOGICS INC., 福佑泰生物制药公司 FILES APPLICATION FOR "BISPECIFIC ANTIBODY-DRUG CONJUGATE TARGETING TROP2XPD-L1 AND PREPARATION METHOD THEREFOR AND USE THEREOF"